Target intelligence / Profile preview

Beta-1,4-galactosyltransferase 2 (B4GALT2)

Target
B4GALT2
Molecular classification
Enzyme, Type II membrane glycoprotein, Glycosyltransferase
01

Overview

Beta-1,4-galactosyltransferase 2 (B4GALT2) is an enzyme responsible for transferring galactose in a beta-1,4 linkage to acceptor sugars (such as N-acetylglucosamine, glucose, and xylose) during the biosynthesis of glycoconjugates, especially N-acetyllactosamine in glycoproteins and glycolipids. It is a type II membrane glycoprotein localized primarily to the Golgi apparatus, where its N-terminal domain serves as a membrane anchor. B4GALT2 displays exclusive specificity for its donor substrate, UDP-galactose, and its substrate specificity can be modified by the presence of alpha-lactalbumin, though it is not active in lactating mammary tissue. This enzyme plays a crucial role in the construction of complex N-linked oligosaccharides and the carbohydrate moieties of glycolipids. Mutations in B4GALT2 are associated with Ehlers-Danlos syndrome, spondylodysplastic type 2. There are several transcript variants encoding different isoforms of the protein.

Other names
Beta4Gal-T2Beta-1,4-GalTase 2Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferaseN-acetyllactosamine synthaseUDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2Lactose synthase A proteinNal synthaseBeta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferaseUDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase 2Beta-4-GalT2EC 2.4.1.38EC 2.4.1.22EC 2.4.1.90B4Gal-T3 (sometimes listed as a synonym, but refers to a distinct gene)
02

Biological functions

GlycosylationSynthesis of N-acetyllactosamineOligosaccharide chain formationGlycolipid/glycoprotein biosynthesis
03

Disease associations

Ehlers-Danlos syndrome, spondylodysplastic type 2possibly involved generally in congenital disorders of glycosylation and related glycosylation-dependent pathologies

Beyond the preview

Go deeper on Beta-1,4-galactosyltransferase 2 (B4GALT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,4-galactosyltransferase 2 (B4GALT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call